|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Articles in PresS, published online ahead of print August 9, 2002
Am J Physiol Lung Cell Mol Physiol, 10.1152/ajplung.00036.2002
Submitted on January 23, 2002
Accepted on July 29, 2002
B ACTIVATION IN LUNG AND LIVER THROUGH TNF TYPE 1 AND IL-1 RECEPTORS
1 Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee, USA
2 Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee, USA; Department of Veterans Affairs Medical Center, Nashville, Tennessee, USA
3 Department of Surgery, Vanderbilt University School of Medicine, Nashville, Tennessee, USA
* To whom correspondence should be addressed. E-mail: timothy.blackwell{at}mcmail.vanderbilt.edu.
We investigated the requirement for TNF
and IL-1 receptors in the pathogenesis of the pulmonary and hepatic responses to Escherichia coli lipopolysaccharide (LPS) by studying wild type mice and mice deficient in TNF type 1 receptor (TNFR1 KO) or both TNF type 1 receptor and type 1 IL-1 receptor (TNFR1/IL-1R KO).In lung tissue, NF-
B activation was similar among the groups following exposure to aerosolized LPS. After intraperitoneal (IP) injection of LPS, NF-
B activation in liver was attenuated in TNFR1KO mice, and further diminished in TNFR1/IL-1R KO mice; however, in lung tissue, no impairment in NF-
B activation was found in TNFR1KO mice and only a modest decrease was found in TNFR1/IL-1R KO mice. Lung concentrations of KC and MIP-2 were lower in TNFR1 KO and TNFR1/IL-1R KO mice following both aerosolized and IP LPS. We conclude that LPS-induced NF-
B activation in liver is mediated through TNF
and IL-1 receptor dependent pathways, but in the lung LPS-induced NF-
B activation is largely independent of these receptors.
This article has been cited by other articles:
![]() |
C. C. Lewis, J. Y. H. Yang, X. Huang, S. K. Banerjee, M. R. Blackburn, P. Baluk, D. M. McDonald, T. S. Blackwell, V. Nagabhushanam, W. Peters, et al. Disease-Specific Gene Expression Profiling in Multiple Models of Lung Disease Am. J. Respir. Crit. Care Med., February 15, 2008; 177(4): 376 - 387. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-Y. Cho, D. L. Morgan, A. K. Bauer, and S. R. Kleeberger Signal Transduction Pathways of Tumor Necrosis Factor-mediated Lung Injury Induced by Ozone in Mice Am. J. Respir. Crit. Care Med., April 15, 2007; 175(8): 829 - 839. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.C. G. Lee, D. A. Knight, K. B. Lane, D. S. Cheng, M. A. Koay, L. R. Teixeira, J. C. Nesbitt, R. C. Chambers, P. J. Thompson, and R. W. Light Activation of proteinase-activated receptor-2 in mesothelial cells induces pleural inflammation Am J Physiol Lung Cell Mol Physiol, April 1, 2005; 288(4): L734 - L740. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. P. Mizgerd, M. M. Lupa, J. Hjoberg, J. C. Vallone, H. B. Warren, J. P. Butler, and E. S. Silverman Roles for early response cytokines during Escherichia coli pneumonia revealed by mice with combined deficiencies of all signaling receptors for TNF and IL-1 Am J Physiol Lung Cell Mol Physiol, June 1, 2004; 286(6): L1302 - L1310. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |